Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹2,182 Cr
Revenue (TTM)
₹383 Cr
Net Profit (TTM)
₹6 Cr
ROE
4.8 %
ROCE
7 %
P/E Ratio
382
P/B Ratio
3
Industry P/E
37.73
EV/EBITDA
60.4
Div. Yield
0.1 %
Debt to Equity
0
Book Value
₹315.8
EPS
₹2.4
Face value
10
Shares outstanding
23,392,055
CFO
₹249.57 Cr
EBITDA
₹467.17 Cr
Net Profit
₹325.70 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tatva Chintan
| 6.4 | 23.6 | 48.5 | -7.3 | -24.5 | -- | -- |
|
BSE Commodities
| 7.8 | 1.5 | 11.7 | 1.2 | 17.7 | 27.1 | -- |
|
BSE Small Cap
| -2.2 | 6.2 | 22.2 | 4.6 | 28.8 | 35.2 | 17.6 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Tatva Chintan
| -44.4 | -25.5 | -19.0 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tatva Chintan
|
946.0 | 2,182.5 | 382.7 | 5.7 | 1.7 | 0.8 | 382 | 3.0 |
| 1,992.6 | 10,159.3 | 1,571.8 | 186.1 | 14.0 | 14 | 54.6 | 7.3 | |
| 1,815.9 | 7,825.8 | 2,550.1 | 357.7 | 22.7 | 22.6 | 21.9 | 4.1 | |
| 2,507.6 | 8,938.5 | 4,223.7 | 304.9 | 8.9 | 13.2 | 29.3 | 3.8 | |
| 623.5 | 5,998.3 | 3,183.5 | 624.2 | 24.0 | 18.7 | 9.6 | 1.7 | |
| 589.4 | 4,336.1 | 4,072.9 | 15.8 | -0.8 | -1.1 | -- | 0.8 | |
| 404.6 | 1,587.4 | 847.9 | 66.8 | 9.5 | 14.2 | 24.8 | 3.4 | |
| 2,854.6 | 9,161.9 | 14,828.2 | 1,254.4 | 13.6 | 8.9 | 14.5 | 1.3 | |
| 3,076.2 | 3,761.5 | 1,744.7 | 152.9 | 11.7 | 22.1 | 24.6 | 5.2 | |
| 569.7 | 3,833.3 | 1,446.6 | 126.6 | 13.1 | 15 | 30.3 | 4.1 |
Analyst's Diary: Out of season
4 min read•By Hemkesh Khattar
IPO update: Tatva Chintan Pharma Chem
3 min read•By Udhayaprakash
Tatva Chintan Pharma: IPO analysis
6 min read•By Rajan Gulati
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor... and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India. Read more
Incorporated
1996
Chairman
Chintan Nitinkumar Shah
Managing Director
Chintan Nitinkumar Shah
Headquarters
Bharuch, Gujarat
Website
Looking for more details about Tatva Chintan Pharma Chem Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification On Price Movement
23-May-2025Clarification On Increase / Spurt In Volume
21-May-2025
The total asset value of Tatva Chintan Pharma Chem Ltd stood at ₹ 836 Cr as on 31-Mar-25
The share price of Tatva Chintan Pharma Chem Ltd is ₹946.00 (NSE) and ₹947.30 (BSE) as of 16-Jun-2025 IST. Tatva Chintan Pharma Chem Ltd has given a return of -24.5% in the last 3 years.
Tatva Chintan Pharma Chem Ltd has a market capitalisation of ₹ 2,182 Cr as on 16-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Tatva Chintan Pharma Chem Ltd is 2.95 times as on 16-Jun-2025, a 54% premium to its peers’ median range of 1.92 times.
The P/E ratio of Tatva Chintan Pharma Chem Ltd is 382.02 times as on 16-Jun-2025, a 913% premium to its peers’ median range of 37.73 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Tatva Chintan Pharma Chem Ltd and enter the required number of quantities and click on buy to purchase the shares of Tatva Chintan Pharma Chem Ltd.
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India.
The prominent promoters of Tatva Chintan Pharma Chem Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Shekhar Rasiklal Somani |
23.07%
|
|
Chintan Nitinkumar Shah |
20.94%
|
|
Ajay Mansukhlal Patel |
17.1%
|
|
Priti Ajay Patel |
3.85%
|
The chairman of the company is Chintan Nitinkumar Shah, and the managing director is Chintan Nitinkumar Shah.
There is no promoter pledging in Tatva Chintan Pharma Chem Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,177
|
|
|
8,811
|
|
|
8,414
|
|
|
7,846
|
|
|
6,036
|
|
|
4,316
|
|
|
3,768
|
|
|
3,714
|
|
|
1,508
|
| Tatva Chintan Pharma Chem Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.77
|
|
Operating margin(%)
|
1.71
|
|
Net Margin(%)
|
1.48
|
|
Dividend yield(%)
|
0.11
|
Yes, TTM profit after tax of Tatva Chintan Pharma Chem Ltd was ₹6 Cr.
₹1.20
(
